Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bio-Manguinhos MR Vaccine in 11-month-old Infants
NCT03148990Phase 3Completed
- Sponsor
- Immunobiological Technology Institute
- Start
- Nov 2018
- Primary completion
- Aug 2020
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of Measles rubella vaccine in measles, rubella, sponsored by Immunobiological Technology Institute. Started Nov 2018; status: completed.
02
Drugs
Measles rubella vaccine
03
Conditions
measlesrubella
Beyond the preview
Go deeper on NCT03148990.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03148990.